The "Anti-Itch" Frontier: How 2026 is Reclaiming the...

a adăugat un sunet Health

2026-02-13 06:39:39 -

The "Anti-Itch" Frontier: How 2026 is Reclaiming the Patient's Quality of Life.

In late 2026, the industry is pivoting toward "Symptomatic Sovereignty." While the search for a "Cure" continues, a radical new class of IBAT inhibitors (like volixibat) is nearing the finish line to treat Pruritus—the debilitating itch that leads many PSC patients to depression. This innovation is a primary driver for the market, as "Quality of Life" scores are finally being used by the...

0 Commentarii 0 Distribuiri 107 Views 0 previzualizare